We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$512M
Cap. Flow %
15.52%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428

Sector Composition

Rank Sector Weight
1 Healthcare 3.28%
2 Communication Services 1.55%
3 Technology 0.91%
4 Consumer Discretionary 0.74%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIS
301
PUT
Nebius Group N.V.
NBIS
$37.6B
$1.99M 0.06%
25,000
IBM icon
302
PUT
IBM
IBM
$213B
$1.99M 0.06%
15,690
+10,460
+200% +$1.4M
BKLN icon
303
PUT
Invesco Senior Loan ETF
BKLN
$6.96B
$1.99M 0.06%
90,000
OXY icon
304
CALL
Occidental Petroleum
OXY
$55.7B
$1.98M 0.06%
66,800
ASAN icon
305
CALL
Asana
ASAN
$1.96B
$1.97M 0.06%
19,000
CCXI
306
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
$1.95M 0.06%
114,200
-23,300
-17% -$363K
GLNG icon
307
PUT
Golar LNG
GLNG
$4.82B
$1.95M 0.06%
150,000
CONE
308
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
$1.94M 0.06%
+25,000
New +$1.88M
BMRN icon
309
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.93M 0.06%
25,000
+14,500
+138% +$1.14M
CTLP
310
DELISTED
Cantaloupe
CTLP
$1.92M 0.06%
178,000
+98,000
+123% +$1.01M
TSM icon
311
TSMC
TSM
$1.94T
$1.9M 0.06%
17,000
+11,500
+209% +$1.35M
CLDX icon
312
CALL
Celldex Therapeutics
CLDX
$2.94B
$1.89M 0.06%
+35,000
New +$1.64M
NTNX icon
313
CALL
Nutanix
NTNX
$16.1B
$1.89M 0.06%
50,000
-48,000
-49% -$1.81M
APO icon
314
Apollo Global Management
APO
$69B
$1.88M 0.06%
30,500
+27,000
+771% +$1.62M
ARWR icon
315
CALL
Arrowhead Research
ARWR
$12.1B
$1.87M 0.06%
30,000
+26,700
+809% +$1.73M
ARWR icon
316
PUT
Arrowhead Research
ARWR
$12.1B
$1.87M 0.06%
+30,000
New +$1.94M
HWM icon
317
CALL
Howmet Aerospace
HWM
$109B
$1.87M 0.06%
60,000
+10,000
+20% +$322K
CNC icon
318
Centene
CNC
$30.5B
$1.87M 0.06%
30,000
+27,000
+900% +$1.8M
CPE
319
CALL
DELISTED
Callon Petroleum Company
CPE
$1.86M 0.06%
37,900
+1,300
+4% +$50.3K
TUP
320
PUT
DELISTED
Tupperware Brands Corporation
TUP
$1.85M 0.06%
+87,700
New +$1.97M
IOVA icon
321
PUT
Iovance Biotherapeutics
IOVA
$2.04B
$1.85M 0.06%
+75,000
New +$1.77M
UTHR icon
322
CALL
United Therapeutics
UTHR
$26.1B
$1.85M 0.06%
+10,000
New +$1.97M
HRC
323
CALL
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.84M 0.06%
+12,300
New +$1.66M
UWMC icon
324
CALL
UWM Holdings
UWMC
$672M
$1.84M 0.06%
264,700
-1,384,600
-84% -$10.3M
AUPH icon
325
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
$1.84M 0.06%
83,000
+74,000
+822% +$1.17M

Similar funds

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.